Piper Jaffray Companies
featured
The apparel maker has recently received both an upgrade and downgrade, so here's where Jim Cramer fits in. » Read More |
A little less optimism means a lower price target for Apple, Gene Munster of Piper Jaffray says. » Read More |
More
-
May 9- Groupon Inc shares were set to open about 11 percent higher on Thursday after the daily deals company reported a strong quarter for its North American business, prompting at least four brokerages to raise their stock price targets. Some analysts said the January-March quarter was an encouraging sign that Groupon has stronger long-term prospects.
-
NEW YORK-- Shares in Corcept Therapeutics Inc. fell Monday after a Piper Jaffray analyst downgraded the stock, pointing to disappointing sales of its endocrine disorder drug Korlym.
-
*Piper Jaffray cuts to neutral- Benzinga.com. Reuters Station users, click. 1568. Reuters Station users, click. 4899 (; ().
-
May 6- Altisource Residential Corp:. *Piper Jaffray starts with overweight- Theflyonthewall.com. Reuters Station users, click. 1568.
-
*Piper Jaffray cuts price target to $6 from $8; rating neutral. Reuters Station users, click. 1568. Reuters Station users, click. 4899.
-
May 3- Le Groupe Jean Coutu PJC Inc:. *CIBC raises price target to $17 from $16; rating sector performer. Reuters Station users, click. 1568.
-
May 3- Rofin-Sinar Technologies Inc:. *Piper Jaffray raises price target to $26 from $20; rating neutral. Reuters Station users, click. 1568.
-
May 2- Le Groupe Jean Coutu PJC Inc:. *Credit Suisse raises target price to C $15 from C $14. Reuters Station users, click. 1568.
-
Facebook users talk about it not as something that lends cachet or that is particularly enjoyable, but as something that's necessary.
-
May 2- JDS Uniphase Corp:. *Piper Jaffray cuts price target to $16 from $18; rating overweight. For a summary of rating and price target changes on U.S. companies: Reuters Eikon users, click on RCH/US Reuters 3000 Xtra users, double-click RCH/US Reuters Station users, click. 1568.
-
May 2- Team Health Holdings Inc:. *Piper Jaffray raises target price to $42 from $40; rating overweight. Reuters Station users, click. 1568.
-
May 2- Silver Spring Networks Inc:. *Piper Jaffray raises target price to $20 from $19; rating neutral. Reuters Station users, click. 1568.
-
May 1- Allergan Inc said approval of its Darpin eye drug could be delayed up to two years, providing a new boost to Regeneron Pharmaceuticals Inc whose successful treatment Eylea stands to gain from a lack of new competition.
-
**MERCK& CO INC, $45.95, down 2 pct. **TITAN PHARMACEUTICALS INC, $0.46, down 73 pct. **NEUTRAL TANDEM INC, $4.57, up 53 pct.
-
*Piper Jaffray cuts target price to $8 from $10; rating neutral. Reuters Station users, click. 1568. Reuters Station users, click. 4899.
-
**MERCK& CO INC, $44.76, down 5 pct. **TITAN PHARMACEUTICALS INC, $0.34, down 80 pct. U.S. health regulators rejected an experimental drug to treat opioid addiction made by Titan Pharmaceuticals and asked for additional data showing it works, the company said.
-
**MERCK& CO INC, $44.76, down 5 pct. **TITAN PHARMACEUTICALS INC, $0.34, down 80 pct. **NEUTRAL TANDEM INC, $4.12, up 38 pct.
-
Wall Street was set for a slightly lower open on Wednesday, weighed by weak results from Merck and as investors waited to hear from the U.S. **MERCK& CO INC, Tuesday close $47, down 5 pct premarket. **CHESAPEAKE ENERGY CORP, Tuesday close $19.54, up 5 pct premarket.
-
Wall Street was set for a flat open on Wednesday as investors waited to hear from the U.S. **MERCK& CO INC, Tuesday close $47, down 5 pct premarket. **CHESAPEAKE ENERGY CORP, Tuesday close $19.54, up 5 pct premarket.
-
May 1- Canada's main stock index looked set to open slightly lower as investors turn cautious ahead of the outcome of the U.S. *Talisman Energy Inc posted a quarterly loss as the sale of some North Sea assets hurt production but it said it expected significant growth in higher-margin liquids output in the second half of this year and into 2014..